Related Experiment Video
Updated: Aug 24, 2025

07:58
Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants
Published on: October 4, 2021
2.7K
Counts of hyaluronic acid-containing extracellular vesicles decrease in naturally occurring equine osteoarthritis.
Anne-Mari Mustonen1,2, Nina Lehmonen3, Sanna Oikari4
1Faculty of Health Sciences, School of Medicine, Institute of Biomedicine, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland. anne-mari.mustonen@uef.fi.
Scientific Reports
|October 20, 2022
Summary
Researchers found fewer hyaluronic acid-containing extracellular vesicles (HA-EVs) in osteoarthritis (OA) horse joint fluid, suggesting HA-EVs may be a biomarker for equine OA diagnosis and treatment.
Area of Science:
- Veterinary Medicine
- Biochemistry
- Cell Biology
Background:
- Osteoarthritis (OA) is a degenerative joint disease causing pain and limited mobility.
- Extracellular vesicles (EVs) in synovial fluid play roles in OA pathogenesis.
- Hyaluronic acid (HA) is a key molecule in joint lubrication, transported by EVs.
Purpose of the Study:
- To characterize synovial fluid (SF) EVs and their HA content in horses with naturally occurring OA.
- To investigate the potential of HA-containing EVs (HA-EVs) as biomarkers for equine OA.
Main Methods:
- Collected SF from control and OA metacarpophalangeal joints in horses.
- Quantified HA concentrations using ELISA and size-exclusion chromatography.
- Utilized nanoparticle tracking analysis (NTA) for small EVs and confocal laser scanning microscopy (CLSM) for larger EVs.
Main Results:
- Small EV counts and size distribution were not significantly affected by OA.
- A decrease in the number and proportion of larger HA-EVs was observed in OA SF.
- Lower total HA concentrations were found in OA joints.
- An inverse association was noted between OA grade and HA-EV counts and percentages.
Conclusions:
- Synovial fluid HA-EVs show potential as a biomarker for naturally occurring equine OA.
- Further research is needed to explore the role of HA-EVs in OA pathogenesis and their therapeutic potential.

